245 related articles for article (PubMed ID: 17447748)
21. Colloidal aggregation: from screening nuisance to formulation nuance.
Ganesh AN; Donders EN; Shoichet BK; Shoichet MS
Nano Today; 2018 Apr; 19():188-200. PubMed ID: 30250495
[TBL] [Abstract][Full Text] [Related]
22. High throughput solubility measurement in drug discovery and development.
Alsenz J; Kansy M
Adv Drug Deliv Rev; 2007 Jul; 59(7):546-67. PubMed ID: 17604872
[TBL] [Abstract][Full Text] [Related]
23. Virtual exploration of the chemical universe up to 11 atoms of C, N, O, F: assembly of 26.4 million structures (110.9 million stereoisomers) and analysis for new ring systems, stereochemistry, physicochemical properties, compound classes, and drug discovery.
Fink T; Reymond JL
J Chem Inf Model; 2007; 47(2):342-53. PubMed ID: 17260980
[TBL] [Abstract][Full Text] [Related]
24. Data mining a small molecule drug screening representative subset from NIH PubChem.
Xie XQ; Chen JZ
J Chem Inf Model; 2008 Mar; 48(3):465-75. PubMed ID: 18302356
[TBL] [Abstract][Full Text] [Related]
25. Design and implementation of an ribonucleic acid (RNA) directed fragment library.
Bodoor K; Boyapati V; Gopu V; Boisdore M; Allam K; Miller J; Treleaven WD; Weldeghiorghis T; Aboul-ela F
J Med Chem; 2009 Jun; 52(12):3753-61. PubMed ID: 19445516
[TBL] [Abstract][Full Text] [Related]
26. Computational advances in combating colloidal aggregation in drug discovery.
Reker D; Bernardes GJL; Rodrigues T
Nat Chem; 2019 May; 11(5):402-418. PubMed ID: 30988417
[TBL] [Abstract][Full Text] [Related]
27. [Chemoinformatics and virtual screening of molecules for therapeutic use].
Vayer P; Arrault A; Lesur B; Bertrand M; Walther B
Med Sci (Paris); 2009 Oct; 25(10):871-7. PubMed ID: 19849994
[TBL] [Abstract][Full Text] [Related]
28. Database of bioactive ring systems with calculated properties and its use in bioisosteric design and scaffold hopping.
Ertl P
Bioorg Med Chem; 2012 Sep; 20(18):5436-42. PubMed ID: 22436390
[TBL] [Abstract][Full Text] [Related]
29. Drug discovery in the kinase inhibitory field using the Nested Chemical Library technology.
Kéri G; Székelyhidi Z; Bánhegyi P; Varga Z; Hegymegi-Barakonyi B; Szántai-Kis C; Hafenbradl D; Klebl B; Muller G; Ullrich A; Erös D; Horváth Z; Greff Z; Marosfalvi J; Pató J; Szabadkai I; Szilágyi I; Szegedi Z; Varga I; Wáczek F; Orfi L
Assay Drug Dev Technol; 2005 Oct; 3(5):543-51. PubMed ID: 16305311
[TBL] [Abstract][Full Text] [Related]
30. How Do Small Molecule Aggregates Inhibit Enzyme Activity? A Molecular Dynamics Study.
Ghattas MA; Al Rawashdeh S; Atatreh N; Bryce RA
J Chem Inf Model; 2020 Aug; 60(8):3901-3909. PubMed ID: 32628846
[TBL] [Abstract][Full Text] [Related]
31. A Method for Identifying Small-Molecule Aggregators Using Photonic Crystal Biosensor Microplates.
Chan LL; Lidstone EA; Finch KE; Heeres JT; Hergenrother PJ; Cunningham BT
JALA Charlottesv Va; 2009 Dec; 14(6):348-359. PubMed ID: 20930952
[TBL] [Abstract][Full Text] [Related]
32. Streamlining lead discovery by aligning in silico and high-throughput screening.
Davies JW; Glick M; Jenkins JL
Curr Opin Chem Biol; 2006 Aug; 10(4):343-51. PubMed ID: 16822701
[TBL] [Abstract][Full Text] [Related]
33. Aqueous solubility and true solutions.
Loftsson T
Pharmazie; 2010 Jun; 65(6):404-7. PubMed ID: 20614686
[TBL] [Abstract][Full Text] [Related]
34. Plate-based diversity selection based on empirical HTS data to enhance the number of hits and their chemical diversity.
Sukuru SC; Jenkins JL; Beckwith RE; Scheiber J; Bender A; Mikhailov D; Davies JW; Glick M
J Biomol Screen; 2009 Jul; 14(6):690-9. PubMed ID: 19531667
[TBL] [Abstract][Full Text] [Related]
35. High-Throughput Hit Screening Cascade to Identify Respiratory Syncytial Virus (RSV) Inhibitors.
Plant H; Stacey C; Tiong-Yip CL; Walsh J; Yu Q; Rich K
J Biomol Screen; 2015 Jun; 20(5):597-605. PubMed ID: 25656237
[TBL] [Abstract][Full Text] [Related]
36. Learning from PAINful lessons.
Erlanson DA
J Med Chem; 2015 Mar; 58(5):2088-90. PubMed ID: 25710486
[TBL] [Abstract][Full Text] [Related]
37. BioProfile--extract knowledge from corporate databases to assess cross-reactivities of compounds.
Beck B
Bioorg Med Chem; 2012 Sep; 20(18):5428-35. PubMed ID: 22633121
[TBL] [Abstract][Full Text] [Related]
38. Activity-aware clustering of high throughput screening data and elucidation of orthogonal structure-activity relationships.
Lounkine E; Nigsch F; Jenkins JL; Glick M
J Chem Inf Model; 2011 Dec; 51(12):3158-68. PubMed ID: 22098146
[TBL] [Abstract][Full Text] [Related]
39. Straightforward recursive partitioning model for discarding insoluble compounds in the drug discovery process.
Lamanna C; Bellini M; Padova A; Westerberg G; Maccari L
J Med Chem; 2008 May; 51(10):2891-7. PubMed ID: 18419111
[TBL] [Abstract][Full Text] [Related]
40. Surface plasmon resonance based assay for the detection and characterization of promiscuous inhibitors.
Giannetti AM; Koch BD; Browner MF
J Med Chem; 2008 Feb; 51(3):574-80. PubMed ID: 18181566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
